Children born with SMA type 1 typically have a life expectancy of around two years
Agency concludes bamlanivimab and etesevimab can be used to treat certain COVID-19 patients
Country's Health Ministry also recommended extending gap between doses to 12 weeks
Late-stage trial results found vaccine gives 91.6% protection against COVID-19
The European Medicines Agency is also reviewing an application for the drug
Pfizer, Moderna and AstraZeneca are all working on modified vaccines
Company is hoping FDA will review data from a UK-based trial
Checkpoint inhibitor gained accelerated approval in 2019
Company has already started shipping doses of the vaccine to the US
Brexit means pharma must review its intellectual property rights across Europe
Continuity and stability are vital when it comes to the EMA's relocation when it leaves London
The committee also gives verdict on three other products
Vaccine can be transported/stored at standard pharmaceutical freezer temperatures
Company is seeking an emergency use authorisation in the US
FDA said that it expects manufacturing information for modified vaccines to remain generally the same
In phase 3, J&J's vaccine was 66% effective overall at preventing moderate-to-severe COVID-19
New approval will see Libtayo compete with blockbuster immunotherapy Keytruda
Submission is based on results from the pivotal REACH3 study
The no-fault compensation fund will be accessible via a web portal by 31 March 2021
Torbett initially joined the pharma association in March 2016
She joins the UK pharma body as its chief scientific officer
Chair of the board Michelle Brennan is among those newly elected
Will move to the global industry body from the Medicines Patent Pool
He joins the biopharma from Tang Capital Management
The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...